Topics and Expertise: HIV

PharmD students assess pharmacist furnishing of HIV medications under California's SB-159

Dong is a world expert on human immunodeficiency virus (HIV) and hepatitis C medication therapy

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

Fran Aweeka, PharmD, will receive renewed funding for her grant from the National Institutes of Health for evaluating the pharmacology of antimalarial drugs in children in Africa. This is a renewal of her R01 on this important work, and will provide five years of funding for Aweeka and her...

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

How do you convince patients who feel fine to take medicines that can have major side effects?

How can you help them stay on their lifesaving daily medications for years to come despite the obstacle course of everyday life?

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

From the time the antiretroviral therapy AZT was introduced in the 1980s to treat AIDS, the drug demanded close patient monitoring to be effective. AZT had many side effects and strict requirements for how and when to take it. Misuse of the drug could lead to viral resistance.